Abstract
Summary
In this report, we study the Veterinary Products for Pet mainly medicines
LPI (LP Information)' newest research report, the “Pet Drug Industry Forecast” looks at past sales and reviews total world Pet Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Pet Drug sales for 2023 through 2029. With Pet Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Drug industry.
This Insight Report provides a comprehensive analysis of the global Pet Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pet Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Drug.
The global Pet Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pet Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pet Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pet Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pet Drug players cover Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol and Meiji, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Antiparasitic Drugs
Antibacterial
Other
Segmentation by application
Dogs
Cats
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell
LPI (LP Information)' newest research report, the “Pet Drug Industry Forecast” looks at past sales and reviews total world Pet Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Pet Drug sales for 2023 through 2029. With Pet Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Drug industry.
This Insight Report provides a comprehensive analysis of the global Pet Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pet Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Drug.
The global Pet Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pet Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pet Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pet Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pet Drug players cover Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol and Meiji, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Antiparasitic Drugs
Antibacterial
Other
Segmentation by application
Dogs
Cats
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Drug Market Size 2018-2029
2.1.2 Pet Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Pet Drug Segment by Type
2.2.1 Antiparasitic Drugs
2.2.2 Antibacterial
2.2.3 Other
2.3 Pet Drug Market Size by Type
2.3.1 Pet Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Pet Drug Market Size Market Share by Type (2018-2023)
2.4 Pet Drug Segment by Application
2.4.1 Dogs
2.4.2 Cats
2.4.3 Other
2.5 Pet Drug Market Size by Application
2.5.1 Pet Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Pet Drug Market Size Market Share by Application (2018-2023)
3 Pet Drug Market Size by Player
3.1 Pet Drug Market Size Market Share by Players
3.1.1 Global Pet Drug Revenue by Players (2018-2023)
3.1.2 Global Pet Drug Revenue Market Share by Players (2018-2023)
3.2 Global Pet Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pet Drug by Regions
4.1 Pet Drug Market Size by Regions (2018-2023)
4.2 Americas Pet Drug Market Size Growth (2018-2023)
4.3 APAC Pet Drug Market Size Growth (2018-2023)
4.4 Europe Pet Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Pet Drug Market Size Growth (2018-2023)
5 Americas
5.1 Americas Pet Drug Market Size by Country (2018-2023)
5.2 Americas Pet Drug Market Size by Type (2018-2023)
5.3 Americas Pet Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Drug Market Size by Region (2018-2023)
6.2 APAC Pet Drug Market Size by Type (2018-2023)
6.3 APAC Pet Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pet Drug by Country (2018-2023)
7.2 Europe Pet Drug Market Size by Type (2018-2023)
7.3 Europe Pet Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet Drug by Region (2018-2023)
8.2 Middle East & Africa Pet Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Pet Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pet Drug Market Forecast
10.1 Global Pet Drug Forecast by Regions (2024-2029)
10.1.1 Global Pet Drug Forecast by Regions (2024-2029)
10.1.2 Americas Pet Drug Forecast
10.1.3 APAC Pet Drug Forecast
10.1.4 Europe Pet Drug Forecast
10.1.5 Middle East & Africa Pet Drug Forecast
10.2 Americas Pet Drug Forecast by Country (2024-2029)
10.2.1 United States Pet Drug Market Forecast
10.2.2 Canada Pet Drug Market Forecast
10.2.3 Mexico Pet Drug Market Forecast
10.2.4 Brazil Pet Drug Market Forecast
10.3 APAC Pet Drug Forecast by Region (2024-2029)
10.3.1 China Pet Drug Market Forecast
10.3.2 Japan Pet Drug Market Forecast
10.3.3 Korea Pet Drug Market Forecast
10.3.4 Southeast Asia Pet Drug Market Forecast
10.3.5 India Pet Drug Market Forecast
10.3.6 Australia Pet Drug Market Forecast
10.4 Europe Pet Drug Forecast by Country (2024-2029)
10.4.1 Germany Pet Drug Market Forecast
10.4.2 France Pet Drug Market Forecast
10.4.3 UK Pet Drug Market Forecast
10.4.4 Italy Pet Drug Market Forecast
10.4.5 Russia Pet Drug Market Forecast
10.5 Middle East & Africa Pet Drug Forecast by Region (2024-2029)
10.5.1 Egypt Pet Drug Market Forecast
10.5.2 South Africa Pet Drug Market Forecast
10.5.3 Israel Pet Drug Market Forecast
10.5.4 Turkey Pet Drug Market Forecast
10.5.5 GCC Countries Pet Drug Market Forecast
10.6 Global Pet Drug Forecast by Type (2024-2029)
10.7 Global Pet Drug Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Zoetis
11.1.1 Zoetis Company Information
11.1.2 Zoetis Pet Drug Product Offered
11.1.3 Zoetis Pet Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Zoetis Main Business Overview
11.1.5 Zoetis Latest Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Pet Drug Product Offered
11.2.3 Boehringer Ingelheim Pet Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Boehringer Ingelheim Main Business Overview
11.2.5 Boehringer Ingelheim Latest Developments
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Information
11.3.2 Merck Animal Health Pet Drug Product Offered
11.3.3 Merck Animal Health Pet Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Merck Animal Health Main Business Overview
11.3.5 Merck Animal Health Latest Developments
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Information
11.4.2 Elanco Animal Health Pet Drug Product Offered
11.4.3 Elanco Animal Health Pet Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Elanco Animal Health Main Business Overview
11.4.5 Elanco Animal Health Latest Developments
11.5 Virbac
11.5.1 Virbac Company Information
11.5.2 Virbac Pet Drug Product Offered
11.5.3 Virbac Pet Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Virbac Main Business Overview
11.5.5 Virbac Latest Developments
11.6 Dechra Veterinary Products
11.6.1 Dechra Veterinary Products Company Information
11.6.2 Dechra Veterinary Products Pet Drug Product Offered
11.6.3 Dechra Veterinary Products Pet Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Dechra Veterinary Products Main Business Overview
11.6.5 Dechra Veterinary Products Latest Developments
11.7 Ceva
11.7.1 Ceva Company Information
11.7.2 Ceva Pet Drug Product Offered
11.7.3 Ceva Pet Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Ceva Main Business Overview
11.7.5 Ceva Latest Developments
11.8 Vetoquinol
11.8.1 Vetoquinol Company Information
11.8.2 Vetoquinol Pet Drug Product Offered
11.8.3 Vetoquinol Pet Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Vetoquinol Main Business Overview
11.8.5 Vetoquinol Latest Developments
11.9 Meiji
11.9.1 Meiji Company Information
11.9.2 Meiji Pet Drug Product Offered
11.9.3 Meiji Pet Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Meiji Main Business Overview
11.9.5 Meiji Latest Developments
11.10 Ouro Fino Saude
11.10.1 Ouro Fino Saude Company Information
11.10.2 Ouro Fino Saude Pet Drug Product Offered
11.10.3 Ouro Fino Saude Pet Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Ouro Fino Saude Main Business Overview
11.10.5 Ouro Fino Saude Latest Developments
11.11 Parnell
11.11.1 Parnell Company Information
11.11.2 Parnell Pet Drug Product Offered
11.11.3 Parnell Pet Drug Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Parnell Main Business Overview
11.11.5 Parnell Latest Developments
12 Research Findings and Conclusion